HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Epigenetics in Cancer: Understanding the role of epigenetic changes in cancer progression.

Epigenetics has become a crucial field in understanding cancer progression. Unlike genetic mutations, which alter the DNA sequence, epigenetic changes affect how genes are turned on or off without changing the underlying DNA code. These modifications can be caused by environmental factors, lifestyle choices, or even inherited traits. In cancer, abnormal epigenetic changes can lead to the activation of oncogenes or the silencing of tumor suppressor genes, contributing to uncontrolled cell growth. Research into epigenetic therapies is exploring how to reverse these changes, potentially offering new treatment options for cancers that are resistant to traditional therapies. Understanding epigenetics also opens new possibilities for early detection and preventive strategies.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp